Shigeki Nakamura

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Ejection Fraction

Klebsiella Pneumoniae

Top Venues

Expert review of vaccines

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu, Naohiro Yonemoto, Camille Moyon, Mark Gouldson, Catriona Crossan, Jeffrey Vietri, Kazumasa Kamei
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan. Expert review of vaccines (2024)
Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu, Naohiro Yonemoto, Camille Moyon, Mark Gouldson, Catriona Crossan, Jeffrey Vietri, Kazumasa Kamei
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan. Expert review of vaccines 23 (1) (2024)
Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu, Naohiro Yonemoto, Camille Moyon, Mark Gouldson, Catriona Crossan, Jeffrey Vietri, Kazumasa Kamei
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan. Expert review of vaccines 23 (1) (2024)
Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu, Naohiro Yonemoto, Camille Moyon, Mark Gouldson, Catriona Crossan, Jeffrey Vietri, Kazumasa Kamei
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan. Expert review of vaccines (2024)
Kazuhiro Ishikawa, Yuki Uehara, Nobuyoshi Mori, Yumiko Mikami, Sayuri Tokioka, Daiki Kobayashi, Hisa Goke, Tatsuya Inukai, Aki Sakurai, Yohei Doi, Sayoko Kawakami, Shizuo Kayama, Motoyuki Sugai, Shigeki Nakamura
In Vitro Activity and Clinical Efficacy of Faropenem against Third-Generation Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae . Antimicrobial agents and chemotherapy 66 (6) (2022)